Paulo Kofuji, PhD, and Alfonso Araque, PhD, both in the Department of Neuroscience, recently received a five-year, $2.2 million grant from the National Institute of Mental Health to study how manipulation of astrocytes – glial cells in the brain – in the brain’s amygdala regulate fear.
Katie Loth, PhD, MPH, RD, in the Department of Family Medicine and Community Health, is leading a study to identify ways that public health practitioners and policymakers can support vulnerable Minnesota families.
Dr. Mustafa al'Absi, an expert in behavioral health, joins WCCO Radio to talk about managing stress during the COVID-19 pandemic.
Please join us for our 22nd Annual Whiteside Memorial Lecture, focusing on COVID-19 research and implications, hosted by the Whiteside Institute for Clinical Research - a collaboration of St. Luke’s and the University of Minnesota Medical School, Duluth Campus.
The Whiteside Institute for Clinical Research seeks grant applications for collaborative clinical and translational research related to preventing or treating cancer, lung disease, or heart disease.
Jesse Williams, PhD, in the Department of Integrative Biology and Physiology, published his team’s study in “Nature Immunology,” which defines the role of a tissue resident macrophage population in the initiation of atherosclerotic lesions within the artery and identifies new gene programs associated with their function in homeostasis and disease.
Mustafa al’Absi, PhD, in the Department of Family Medicine and Biobehavioral Health, talks about ways to recognize and reduce stress during the COVID-19 pandemic and beyond.
The University of Minnesota Medical School’s Department of Laboratory Medicine and Pathology has been selected as a Capacity Building Center for a new national network dedicated to serological, or antibody sciences.
Anna Wirta Kosobuski, EdD, in the Department of Biomedical Sciences on the Duluth campus, received a COVID-19 grant to identify elements for effective, culturally-grounded therapy models for Native American youth.
A significant grant from METAvivor worth $500,000 over three years will allow Carol Lange, PhD, a professor in the Department of Medicine and Pharmacology, to analyze the biological mechanisms behind breast cancer, particularly how steroid hormone receptors impact the disease.